# Contact PT-141 Legit

> Contact the editorial team at PT-141 Legit. Editorial correspondence only — we do not provide medical advice, we do not sell or distribute any product, and we cannot answer individual dosing or sourcing questions.

Editorial correspondence — corrections to citations, requests to add a published source, notes on the digest. We do not provide medical advice and we cannot answer individual dosing or sourcing questions.

## Editorial correspondence

PT-141 Legit accepts editorial correspondence on the published digest — corrections to citations, requests to add a published primary source we may have missed, notes on the editorial framing of a claim. We read every message and reply when a substantive editorial response is warranted.

We do not, however, provide individualized advice. We cannot answer:

- Whether PT-141 is appropriate for you or any individual
- What dose to take, what schedule to use, or how to self-administer
- Where to purchase any form of the compound
- How to evaluate any specific research-peptide vendor or pharmacy
- Whether a particular adverse event is concerning

Those questions belong with a licensed clinician who can examine the patient, review the medical history, and prescribe within the scope of an established clinical relationship. Nothing on this site substitutes for that relationship.

## Editorial note

All correspondence is read by the editorial team only. Citations and content updates are batched and published on a non-fixed schedule. We do not maintain a public comment section.

---

A typographic dossier on the bremelanotide literature — RECONNECT, the Vyleesi label, the independent re-analysis — set in one geometric sans, sold to no one.